-+ 0.00%
-+ 0.00%
-+ 0.00%

TG Therapeutics Announces Upcoming Schedule Of Presentations Highlighting BRIUMVI Data In Patients With RMS, At 2025 CMSC Annual Meeting

Benzinga·05/27/2025 11:37:40
Listen to the news

TG Therapeutics, Inc. (NASDAQ:TGTX), today announced the upcoming schedule of presentations highlighting BRIUMVI® (ublituximab-xiiy) data in patients with relapsing forms of multiple sclerosis (RMS), at the 2025 Consortium of Multiple Sclerosis Centers (CMSC) annual meeting, being held May 28-31, 2025 in Phoenix, Arizona. Abstracts are now available online and can be accessed on the CMSC meeting website at www.mscare.org/2025